LIFE by Dr. Pat Fertility & OB-GYN Specialty Clinic · License No. 10102004165
✍️ By Dr. Patsama Vichinsartvichai, MD, MClinEmbryol, EFOG-EBCOG, EFRM-ESHRE/EBCOG, FACOG — Reproductive Medicine Specialist · Updated August 2026
Gonadotropins are the workhorse of IVF stimulation. Multiple options exist, each with distinct properties. This guide helps patients understand the differences.
Gonal-F and Puregon are functionally interchangeable. Rekovelle has a more acidic isoform profile, longer half-life, and higher potency per μg. Ferring recommends dosing by AMH and weight rather than IU-equivalence.
Menopur provides both FSH and LH activity — helpful in patients with low endogenous LH or poor response.
Meta-analyses show no significant difference in pregnancy rates between rFSH and hMG. Rekovelle shows lower OHSS incidence while maintaining pregnancy rates.
No single "best" drug exists. Individualization based on age, AMH, weight, previous response, and OHSS risk is essential.
Dr. Patsama Vichinsartvichai, MD, MClinEmbryol, EFOG-EBCOG, EFRM-ESHRE/EBCOG, FACOG is a board-certified reproductive endocrinology & infertility specialist, former head of the Vajira IVF unit at Navamindradhiraj University, and founder of LIFE by Dr. Pat in Bangkok. His published research focuses on the dysmorphic (T-shaped) uterus and uterine-factor infertility.
Meet Dr. Patsama →